Dysregulated cholesterol regulatory genes in hepatocellular carcinoma

被引:0
|
作者
Dan Cao
Huan Liu
机构
[1] Affiliated Hospital of North Sichuan Medical College,Department of Respiratory and Critical Care Medicine
[2] West China Hospital of Sichuan University,Center of Infectious Diseases
来源
European Journal of Medical Research | / 28卷
关键词
Hepatocellular carcinoma; Cholesterol; Tumorigenesis; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Cholesterol is an indispensable component in mammalian cells, and cholesterol metabolism performs important roles in various biological activities. In addition to the Warburg effect, dysregulated cholesterol metabolism is one of the metabolic hallmarks of several cancers. It has reported that reprogrammed cholesterol metabolism facilitates carcinogenesis, metastasis, and drug-resistant in various tumors, including hepatocellular carcinoma (HCC). Some literatures have reported that increased cholesterol level leads to lipotoxicity, inflammation, and fibrosis, ultimately promoting the development and progression of HCC. Contrarily, other clinical investigations have demonstrated a link between higher cholesterol level and lower risk of HCC. These incongruent findings suggest that the connection between cholesterol and HCC is much complicated. In this report, we summarize the roles of key cholesterol regulatory genes including cholesterol biosynthesis, uptake, efflux, trafficking and esterification in HCC. In addition, we discuss promising related therapeutic targets for HCC.
引用
收藏
相关论文
共 50 条
  • [41] Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma
    Song, Lishan
    Xu, Chaojie
    Zhang, Tong
    Chen, Shengyang
    Hu, Shuiquan
    Cheng, Bingbing
    Tong, Hao
    Li, Xiaoyong
    FRONTIERS IN GENETICS, 2022, 13
  • [42] The Role of Autophagy in Hepatocellular Carcinoma
    Lee, Yoo Jin
    Jang, Byoung Kuk
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (11) : 26629 - 26643
  • [43] Expression of cellular adhesion regulatory molecule in hepatocellular carcinoma
    Sunaga, M
    Yoshikawa, M
    Ebara, M
    Kondo, F
    Kashiwada, M
    Takemori, T
    Saisho, H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (09) : 878 - 884
  • [44] Differential expression of sprouty genes in hepatocellular carcinoma
    Sirivatanauksorn, Yongyut
    Sirivatanauksorn, Vorapan
    Srisawat, Chatchawan
    Khongmanee, Amnart
    Tongkham, Chalita
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (03) : 273 - 276
  • [45] Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
    Ma, Shiwen
    Adzavon, Yao Mawulikplimi
    Wen, Xiaohu
    Zhao, Pengxiang
    Xie, Fei
    Liu, Mengyu
    Ma, Xuemei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [46] Construction of a prognosis-predicting model based on autophagy-related genes for hepatocellular carcinoma (HCC) patients
    Zhu, Yayun
    Wang, Ru
    Chen, Wanbin
    Chen, Qiuyu
    Zhou, Jian
    AGING-US, 2020, 12 (14): : 14582 - 14592
  • [47] Melatonin modulates dysregulated circadian clocks in mice with diethylnitrosamine-induced hepatocellular carcinoma
    Sanchez, Diana I.
    Gonzalez-Fernandez, Barbara
    Crespo, Irene
    San-Miguel, Beatriz
    Alvarez, Marcelino
    Gonzalez-Gallego, Javier
    Jesus Tunon, Maria
    JOURNAL OF PINEAL RESEARCH, 2018, 65 (03)
  • [48] The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma
    Ghionescu, Alina-Veronica
    Sorop, Andrei
    Dima, Simona Olimpia
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [49] N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
    Regmi, Parbatraj
    He, Zhi-Qiang
    Lia, Thongher
    Paudyal, Aliza
    Li, Fu-Yu
    FRONTIERS IN GENETICS, 2022, 13
  • [50] Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
    Zhou, Fangli
    Sun, Xiaoli
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9